ArticleCancer management and research2026
Association Between ABO Blood Group and Survival in Early-Stage Colon Cancer: A Single-Center Retrospective Cohort Analysis.
Article in Cancer management and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: ABO blood group antigens influence cell adhesion, inflammation, and metastatic processes, raising interest in their potential prognostic role in colorectal cancer. However, previous studies have reported inconsistent findings. This study evaluated the association between ABO blood group and overall survival (OS) in early-stage colon cancer patients undergoing curative surgery. Methods: This retrospective cohort included patients with pathologic stage II-III colon adenocarcinoma treated surgically between 2016 and 2024 at a single-center institution. Demographic, clinicopathological, and laboratory data-including ABO blood group-were collected. OS was analyzed using Kaplan-Meier and Log rank tests, and independent prognostic factors were assessed with multivariable Cox regression. Results: A total of 158 patients were included (median age 59 years; 63.3% male). Blood group distribution was: O (39.2%), A (38.6%), B (12.7%), and AB (9.5%). During a median follow-up of 31 months, 17.7% of patients died. Blood group B demonstrated significantly shorter OS compared with group O (log-rank p=0.014). In the multivariable analysis, only blood group B remained an independent predictor of worse OS (HR=1.99; 95% CI: 1.11-3.60; p=0.022). Conclusion: Blood group B is independently associated with poorer survival in early-stage colon cancer. ABO typing may represent a potential adjunctive prognostic marker, warranting validation in larger prospective cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.